ATP5F1D
ATP synthase F(1) complex subunit delta, mitochondrial
Also known as: ATP5D, ATPD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30049
- Gene
- ATP5F1D
- Ensembl
- ENSG00000099624
- Chromosome
- 19
- Canonical length
- 168 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria,Connecting piece,Flagellar centriole,Principal piece
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the delta subunit of the catalytic core. Alternatively spliced transcript variants encoding the same isoform have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
168 residues, UniProt reviewed canonical sequence.
>P30049|ATP5F1D
1 MLPAALLRRP GLGRLVRHAR AYAEAAAAPA AASGPNQMSF TFASPTQVFF NGANVRQVDV
61 PTLTGAFGIL AAHVPTLQVL RPGLVVVHAE DGTTSKYFVS SGSIAVNADS SVQLLAEEAV
121 TLDMLDLGAA KANLEKAQAE LVGTADEATR AEIQIRIEAN EALVKALELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5F1D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 784 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 784 nTPM
- heart muscle: 549 nTPM
- liver: 355 nTPM
- kidney: 261 nTPM
- pancreas: 243 nTPM
- cerebral cortex: 232 nTPM
Single-cell type
- colonocytes: 1,788 nCPM
- parietal cells: 1,729 nCPM
- enterocytes: 1,696 nCPM
- esophageal suprabasal cells: 1,468 nCPM
- esophageal basal cells: 1,232 nCPM
- enteric transient amplifying cells: 1,080 nCPM
Immune cell
- plasmacytoid DC: 350 nTPM
- myeloid DC: 322 nTPM
- naive B-cell: 288 nTPM
- intermediate monocyte: 288 nTPM
- T-reg: 288 nTPM
- memory B-cell: 285 nTPM
Brain region
- medulla oblongata: 211 nTPM
- thalamus: 207 nTPM
- pons: 201 nTPM
- cerebellum: 200 nTPM
- cerebral cortex: 190 nTPM
- hypothalamus: 172 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5F1D.
Disease | AllUniProt
Conditions ATP5F1D is implicated in, by any mechanism.
- Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) MIM:618120
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 171 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex V (ATP synthase) deficiency, nuclear type 5
- Decreased activity of mitochondrial ATP synthase complex
- Mitochondrial disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0.07
- DepMap mean gene effect
- -0.69
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial proton-transporting ATP synthase complex assembly
- proton motive force-driven ATP synthesis
- proton motive force-driven mitochondrial ATP synthesis
- response to copper ion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP synthase, F1 complex, delta/epsilon subunit
- ATP synthase, F1 complex, delta/epsilon subunit, N-terminal
- F0F1 ATP synthase delta/epsilon subunit, N-terminal
- ATP synthase delta/epsilon subunit, C-terminal domain superfamily
- F1F0-ATP synthase delta subunit, C-terminal domain, metazoan
- ATP synthase, Delta/Epsilon chain, beta-sandwich domain
- Metazoan delta subunit of F1F0-ATP synthase, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5F1D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5F1D as an antibody target. Whether an autoantibody or antibody against ATP5F1D could matter depends on whether native ATP5F1D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5F1D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5F1D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...